Trial Evaluating the Efficacy and the Safety of FOLFIRINOX3 Treatment in Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer in First Line of Chemotherapy

Clinical trial NCT05988814 · RECRUITING

Trial details

NCT number

NCT05988814

Sponsor

Centre Georges Francois Leclerc

Status

RECRUITING

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2024-01-24

Primary completion

2029-07-24

Enrollment

90

View on ClinicalTrials.gov